US Patent 10907160 Methods for reducing LRRK2 expression
Patent 10907160 was granted and assigned to Ionis Pharmaceuticals on February, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
January 5, 2017
0
Date of Patent
February 2, 2021
0
Patent Applicant
Patent Application Number
16063903
0
Patent Inventor Names
Holly Kordasiewicz
0
Hien Thuy Zhao
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10907160 Methods for reducing LRRK2 expression
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.